SpinalCyte received IRB approval to commence Phase I clinical trials with its CybroCell dermal fibroblast cell product in the treatment of degenerative disc disease.
Zimmer Biomet announced positive outcomes associated with use of Trabecular Metal™ Cups in >9,500 revision hip arthroplasty cases, as reported in data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.
Zimmer Biomet reports that most product lines impacted by previously-disclosed shipping delays have returned to full shipping capacity, and disclosed the receipt of a Form 483 following an FDA inspection of a legacy Biomet manufacturing site in Warsaw, Indiana.
Zimmer Biomet launched PrimaGen Advancedâ„¢ Allograft, an autograft substitute comprising cancellous bone + demineralized cortical bone fibers with verified osteoinductivity.
Results from a study of Zyga Technology’s SImmetry® Sacroiliac Joint Fusion procedure indicate that, at 12 months, fusion was reported in 88% of patients and back pain decreased by 46%.
Arthrex was granted US $17MM+ in damages following a jury finding of willful infringement by Smith & Nephew/ArthroCare on two Arthrex patents relative to knotless and cross-support technology.